BJOG : an international journal of obstetrics and gynaecology
-
Randomized Controlled Trial
Transdermal clonidine in the treatment of severe hyperemesis. A pilot randomised control trial: CLONEMESI.
To study the efficacy of transdermal clonidine in the treatment of severe refractory hyperemesis gravidarum (HG), the most severe illness of pregnancy. ⋯ This preliminary RCT demonstrates the efficacy of transdermal clonidine in the treatment of severe HG, leading to a significant reduction of symptoms and reducing the need for other supportive measures and medications.